Company Overview
AGIOS PHARMACEUTICALS, INC.
AGIORevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
54M
2025 FY
Net Income
-413M
2025 FY
Shares Outstanding
58M
2025 FY
EPS
-7.12USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1439222
Exchange
Nasdaq
Location
US